Pathogenesis of spinal cord injury.
D000818:Animals; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D001808:Blood Vessels / Q000293:injuries; D002395:Catecholamines / Q000378:metabolism; D002415:Cats; D003911:Dextrans / Q000627:therapeutic use; D004285:Dogs; D004487:Edema / Q000150:complications; D000882:Haplorhini; D006801:Humans; D006931:Hyperbaric Oxygenation; D006940:Hyperemia / Q000150:complications; D007036:Hypothermia, Induced; D007511:Ischemia / Q000150:complications; D008353:Mannitol / Q000627:therapeutic use; D011134:Polysaccharides / Q000627:therapeutic use; D012039:Regional Blood Flow; D013116:Spinal Cord / Q000098:blood supply; D013119:Spinal Cord Injuries / Q000378:metabolism / Q000503:physiopathology* / Q000628:therapy; D013256:Steroids / Q000627:therapeutic use; D013454:Sulfoxides / Q000627:therapeutic use
D000933:Antifibrinolytic Agents; D002395:Catecholamines; D003911:Dextrans; D011134:Polysaccharides; D013256:Steroids; D013454:Sulfoxides; D008353:Mannitol